ADAP
Two Sigma Investments’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-135,947
| Closed | -$26.8K | – | 3104 |
|
|
2025
Q1 | $26.8K | Buy |
135,947
+59,600
| +78% | +$11.7K | ﹤0.01% | 3023 |
|
|
2024
Q4 | $41.1K | Buy |
76,347
+19,146
| +33% | +$10.3K | ﹤0.01% | 2996 |
|
|
2024
Q3 | $54.4K | Buy |
+57,201
| New | +$54.4K | ﹤0.01% | 2898 |
|
|
2024
Q2 | – | Sell |
-14,474
| Closed | -$22.9K | – | 2915 |
|
|
2024
Q1 | $22.9K | Buy |
+14,474
| New | +$22.9K | ﹤0.01% | 2847 |
|
|
2023
Q4 | – | Sell |
-60,074
| Closed | -$46.9K | – | 3028 |
|
|
2023
Q3 | $46.9K | Sell |
60,074
-50,100
| -45% | -$39.1K | ﹤0.01% | 2746 |
|
|
2023
Q2 | $102K | Buy |
110,174
+94,774
| +615% | +$87.7K | ﹤0.01% | 2676 |
|
|
2023
Q1 | $16.8K | Sell |
15,400
-7,200
| -32% | -$7.85K | ﹤0.01% | 2785 |
|
|
2022
Q4 | $33K | Buy |
+22,600
| New | +$33K | ﹤0.01% | 2580 |
|
|
2022
Q2 | – | Sell |
-263,960
| Closed | -$544K | – | 2386 |
|
|
2022
Q1 | $544K | Buy |
+263,960
| New | +$544K | ﹤0.01% | 1942 |
|